Clinical presentation and possible contributing factors to SGLT2 inhibitor-associated DKA Nausea and vomiting were the most common presenting symptoms of SGLT2 inhibitor-associated DKA, followed by general weakness, dyspnea, abdominal pain, and mental changes (Table 2)
A common vascular anomaly
*Correspondence: Li Chen, [email protected] This article was submitted to Gut Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Published dermatological research, including a 2017 randomized controlled study in the Journal of Clinical and Aesthetic Dermatology, documented measurable improvements in skin brightness among participants receiving glutathione
This cycle underscores the vagus nerves pivotal role in hunger and satiety regulation